![Mark Devlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark Devlin formerly worked at CTxONE, as Chief Executive Officer, Oncology One Pty Ltd., as Chief Operating Officer from 2018 to 2019, Peter MacCallum Cancer Institute, as Associate Professor from 2008 to 2019, and Amplia Therapeutics Ltd., as Chief Scientific Advisor.
Dr. Devlin received his Masters Business Admin degree from Melbourne Business School and doctorate degree from the University of Melbourne.
Anciens postes connus de Mark Devlin
| Sociétés | Poste | Fin |
|---|---|---|
Peter MacCallum Cancer Institute
 Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services | Corporate Officer/Principal | 01/09/2019 |
Oncology One Pty Ltd.
 Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer | Directeur des opérations | 01/09/2019 |
CTxONE | Directeur Général | - |
| AMPLIA THERAPEUTICS LIMITED | Directeur Technique/Scientifique/R&D | - |
Formation de Mark Devlin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncology One Pty Ltd.
Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Peter MacCallum Cancer Institute
Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services | Government |
Amplia Therapeutics Ltd.
 Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis | Health Technology |
CTxONE |
